Moleculin Biotech Inc.
MBRX | NASDAQ
$0.52
-$0.25 (-32.74%)
At close: Sep 21, 2026, 4:00 PM ET
$0.52
$0 (+0.62%)
Pre-market:
Sep 22, 2026, 7:44 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 8K | n/a | n/a | 29K | n/a | 31K | n/a | n/a | n/a | 35K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -8K | n/a | n/a | -29K | n/a | -31K | n/a | n/a | n/a | -35K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -7.56M | -7.87M | -7.53M | -5.91M | -5.72M | -5.94M | -6.64M | -7.14M | -6.19M | -6.68M | -8.92M | -5.95M | -6.41M | -8.35M | -7.05M | -9.08M | -7.43M | -7.07M | -5.21M | -6.16M | -5.52M | -6.09M |
Interest Income | n/a | 34K | 9K | 39K | 26K | 30K | 47K | 102K | 159K | 241K | 262K | 324K | 390K | 392K | 126K | 33K | 39K | 42K | 70K | 87K | 92K | 57K |
Pretax Income | -7.64M | -12.85M | 15.55M | -25.4M | -7.64M | -6.44M | -1.88M | -10.59M | -4.32M | -4.97M | -10.27M | -5.61M | -5.98M | -7.92M | -6.77M | -8.61M | -6.78M | -6.87M | -2.83M | -4.38M | -4.24M | -4.45M |
Net Income | -7.64M | -12.85M | 15.55M | -25.4M | -7.64M | -6.44M | -1.88M | -10.59M | -4.32M | -4.97M | -10.27M | -5.61M | -5.98M | -7.92M | -6.77M | -8.61M | -6.78M | -6.87M | -2.83M | -4.38M | -4.24M | -4.45M |
Selling & General & Admin | 2.1M | 2.49M | 2.41M | 2.15M | 2.09M | 2.48M | 2.16M | 2.17M | 2.06M | 2.39M | 2.25M | 2.64M | 2.49M | 2.64M | 2.84M | 3.09M | 3.2M | 2.42M | 1.99M | 2.02M | 2.43M | 1.94M |
Research & Development | 5.45M | 5.38M | 5.12M | 3.74M | 3.6M | 3.44M | 4.46M | 4.93M | 4.09M | 4.25M | 6.63M | 3.28M | 3.89M | 5.69M | 4.18M | 5.97M | 4.2M | 4.62M | 3.18M | 4.1M | 3.04M | 4.11M |
Other Expenses | 8K | 8K | 9K | 21K | n/a | 31K | n/a | 31K | 31K | 32K | n/a | 32K | 31K | 30K | 32K | 32K | 34K | 32K | 34K | 41K | 44K | 44K |
Operating Expenses | 7.56M | 7.87M | 7.53M | 5.91M | 5.69M | 5.94M | 6.61M | 7.14M | 6.19M | 6.68M | 8.88M | 5.95M | 6.41M | 8.35M | 7.05M | 9.08M | 7.43M | 7.07M | 5.21M | 6.16M | 5.52M | 6.09M |
Interest Expense | 78K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 7.56M | 7.87M | 7.53M | 5.91M | 5.72M | 5.94M | 6.64M | 7.14M | 6.19M | 6.68M | 8.92M | 5.95M | 6.41M | 8.35M | 7.05M | 9.08M | 7.43M | 7.07M | 5.21M | 6.16M | 5.52M | 6.09M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 5.68M | 4.12M | 3.2M | 1.49M | 621.06K | 373.75K | 135.16K | 148.57K | 101.73K | 98.65K | 80.13K | 79.49K | 79.17K | 76.67K | 76.34K | 76.34K | 76.22K | 76.21K | 76.21K | 76.2K | 75.87K | 58.16K |
Shares Outstanding (Diluted) | 5.68M | 4.12M | 3.2M | 1.49M | 621.06K | 373.75K | 135.16K | 148.57K | 101.73K | 98.65K | 80.13K | 79.49K | 79.17K | 76.67K | 76.34K | 76.34K | 76.22K | 76.21K | 76.21K | 76.2K | 75.87K | 58.16K |
EPS (Basic) | -1.40 | -3.54 | 4.83 | -17.02 | -12.30 | -15.80 | -48.71 | -47.28 | -42.46 | -50.38 | -128.15 | -70.56 | -75.48 | -103.24 | -88.68 | -112.80 | -88.91 | -90.11 | -37.07 | -57.47 | -55.94 | -76.43 |
EPS (Diluted) | -1.40 | -3.54 | 4.83 | -17.02 | -12.30 | -15.80 | -48.71 | -47.28 | -42.46 | -50.38 | -128.15 | -70.56 | -75.48 | -103.24 | -88.68 | -112.80 | -88.91 | -90.11 | -37.07 | -57.47 | -55.94 | -76.43 |
EBITDA | -7.56M | -12.84M | 15.56M | -25.38M | -7.61M | -6.41M | -1.85M | -10.56M | -4.29M | -4.94M | -10.23M | -5.58M | -5.95M | -7.89M | -6.74M | -8.58M | -6.74M | -6.84M | -2.79M | -4.34M | -4.2M | -6.04M |
EBIT | -7.57M | -12.85M | 15.55M | -25.4M | -7.64M | -6.44M | -1.88M | -10.59M | -4.32M | -4.97M | -10.27M | -5.61M | -5.98M | -7.92M | -6.77M | -8.61M | -6.78M | -6.87M | -2.83M | -4.38M | -4.24M | -6.09M |
Depreciation & Amortization | 8K | 8K | 9K | 22K | 29K | 31K | 31K | 32K | 31K | 32K | 35K | 31K | 31K | 30K | 32K | 32K | 34K | 32K | 34K | 42K | 44K | 44K |
Add to Watchlist
Select watchlists to add or remove MBRX